Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
26.00
+2.75 (11.83%)
At close: Jan 9, 2026, 4:00 PM EST
26.11
+0.11 (0.42%)
After-hours: Jan 9, 2026, 7:58 PM EST
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.54 billion as of January 9, 2026. Its market cap has increased by 34.79% in one year.
Market Cap
1.54B
Enterprise Value
1.07B
1-Year Change
34.79%
Ranking
Category
Stock Price
$26.00
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.54B, an increase of 58.42%. That is a compound annual growth rate of 17.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.54B | 68.83% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |